Paymentus is scaling its bill payment platform into new sectors like utilities, insurance, and government by enhancing security with agentic AI and expanding its Billeo and BillWallet services. CEO Dushyant Sharma emphasized the platform's role beyond transactions, focusing on data, workflows, and technology to handle 16-17 billion U.S. bills annually. CFO Sanjay Kalra highlighted strong financial performance with 70% incremental EBITDA margins and a strategy targeting 20% annual revenue growth. The company favors organic growth on a unified code base over acquisitions to maintain efficiency and scale across multiple verticals.
Paymentus scaling its bill payment platform into new sectors provides context for technology market activity. For readers following the Technology sector, here is Pluang's market snapshot as of Sep 15, 2026 04:22 WIB: out of 150 priced US tech stocks, 77 rose and 71 fell. Notable movers include HubSpot Inc (HUBS) at USD 250.00 with a 1-day change of +10.95%, AXT Inc (AXTI) at USD 57.92 down 10.58%, and Hewlett Packard Enterprise Co (HPE) at USD 55.60 down 10.45%.
UBS maintains a Buy rating on Burberry, stating the luxury brand remains undervalued despite recent sales and margin improvements. UBS lowered its price target to 1,320p but still sees 30% upside from the current share price. The bank highlights Burb...
FingerMotion announced a definitive agreement to acquire Newbit Technology's Alberta infrastructure site for $2.3 million, excluding generating equipment, with closing expected by October 29, 2026. Alset AI holds a 2.2% stake in FingerMotion and a co...
Zentek Ltd. announced that its CEO will present bench-scale results of ultra-pure Albany graphite at the 26th International Nuclear Graphite Specialists Meeting (INGSM-26) in Osaka, Japan, on October 22, 2026. The graphite achieved up to 99.99985% pu...
VanEck's Matthew Sigel projects Bitcoin could reach $500,000 if its market capitalization grows to half that of gold, a medium-term target. This view is supported by Bitcoin's recovering price toward $88,000 and strong institutional demand, including...
Nyxoah, a small medical device company, is entering a growth phase with its Genio implant targeting the Obstructive Sleep Apnea (OSA) market. The company aims to capture 30% of the OSA device market by 2027, contingent on FDA approval for an expanded...
